Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients With Cancer- Or Chemotherapy-Induced Anemia

Oncology - Switzerland
doi 10.1159/000330738
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis- Stimulating Agents (ESA) for Cancer Patients With Anaemia: A Systematic Review and Network Meta-Analysis

Cochrane Database of Systematic Reviews
2017English

Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents

Current Medical Research and Opinion
Medicine
2008English

Managing Chemotherapy Induced Anemia With Darbepoetin Alfa and Other Erythropoiesis Stimulating Agents: A Nurse's Perspective

Nursing: Research and Reviews
2013English

The Effect of Zinc Supplementation on Erythropoiesis-Stimulating Agent Hyporesponsive Anemia and Nutritional Status in a Zinc-Deficient Hemodialysis Patient

Nihon Toseki Igakkai Zasshi
2011English

Iron Deficient Erythropoiesis Might Play Key Role in Development of Anemia in Cancer Patients

Oncotarget
Oncology
2015English

Economic Evaluation of Intravenous Iron Treatments in the Management of Anemia Patients in Greece

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2012English

Darbepoetin Alpha in the Treatment of Cancer Chemotherapy-Induced Anemia

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy